Clinical Trial Update: Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating postoperative adjuvant therapy for hepatocellular carcinoma patients with positive TB; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University | Conditions: Carcinoma, Hepatocellular | Phase 4 | Status: NOT_YET_RECRUITING